Non-Vitamin K Antagonist Oral Anticoagulants: A Concise Guide
There are several disorders which carry an increased risk of thrombosis, clots that interfere with normal circulation, including: venous thromboembolism (VTE), comprising both deep vein thrombosis (DVT) and pulmonary embolism (PE), atrial fibrillation (AF), acute coronary syndromes (ACS), valve dise...
- Autores:
- Tipo de recurso:
- Book
- Fecha de publicación:
- 2016
- Institución:
- Universidad de Bogotá Jorge Tadeo Lozano
- Repositorio:
- Expeditio: repositorio UTadeo
- Idioma:
- eng
- OAI Identifier:
- oai:expeditiorepositorio.utadeo.edu.co:20.500.12010/18737
- Acceso en línea:
- https://directory.doabooks.org/handle/20.500.12854/35698
http://hdl.handle.net/20.500.12010/18737
- Palabra clave:
- Hematology
Surgery
Cardiology
Anticoagulantes (Medicina)
Antitrombinas
Antivitaminas
- Rights
- License
- Abierto (Texto Completo)
| Summary: | There are several disorders which carry an increased risk of thrombosis, clots that interfere with normal circulation, including: venous thromboembolism (VTE), comprising both deep vein thrombosis (DVT) and pulmonary embolism (PE), atrial fibrillation (AF), acute coronary syndromes (ACS), valve disease and endocarditis, and conditions associated with a raised risk of ischemic stroke. Due to this increased risk, a number of thromboprophylactic medications target the coagulation cascade. Effective anticoagulation can be achieved by inhibiting different coagulation factors in the coagulation cascade. |
|---|